Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Raymond Kim

Denver, CO Medical Doctor

NPI 1861440133 CMS profile 1310368

2535 S Downing St, Ste 100, Denver, CO 80210

Open in the dashboard

General payments

$4,234,877

529 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Raymond Kim of Denver, CO is reported in the CMS Open Payments database as having received $4,234,877 across 529 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,065,629 75
2024 General $76,810 47
2023 General $908,851 70
2022 General $818,360 134
2021 General $598,340 86
2020 General $386,439 23
2019 General $380,448 94

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Raymond Kim
  • Colorado median
  • Middle half of Colorado
  • National median

In program year 2025, general payments to Raymond Kim were reported at $1,065,629. Among 17,059 Colorado profiles paid that year, the median was $144 and the middle half received between $41 and $532.

Show as a table
Year Raymond Kim Colorado median Middle half National median
2019 $380,448 $137 $40–$561 $163
2020 $386,439 $109 $32–$371 $114
2021 $598,340 $127 $33–$475 $132
2022 $818,360 $136 $40–$504 $149
2023 $908,851 $144 $43–$511 $160
2024 $76,810 $144 $42–$500 $164
2025 $1,065,629 $144 $41–$532 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Encore Medical, LP $4,217,967 483 payments
  2. ConvaTec Inc. $12,025 4 payments
  3. Stryker Corporation $1,301 10 payments
  4. Insight Medical Systems, Inc. $800 1 payment
  5. Zimmer Biomet Holdings, Inc. $559 5 payments
  6. Smith+Nephew, Inc. $512 4 payments
  7. Heron Therapeutics, Inc. $317 3 payments
  8. Bioventus LLC $263 2 payments
  9. Baudax Bio Inc. $257 2 payments
  10. Medline Industries, Inc. $185 2 payments
  11. Other $691 13 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $3,748,412 25 payments
  2. Consulting Fee $430,877 290 payments
  3. Travel and Lodging $45,808 99 payments
  4. Food and Beverage $9,780 115 payments
Products named General payments · program years 2019–2025
  1. DJO SURGICAL Joint Implants $1,717,431 129 payments
  2. DJO SURGICAL $1,511,132 22 payments
  3. DJO SURGICAL Joint Implants $1,504,574 8 payments
  4. DJO SURGICAL Joint Implants $1,504,574 8 payments
  5. DJO Surgical Empowr Knee System Joint Implants $749,501 53 payments
  6. DJO Surgical Empowr Knee System Joint Implants $568,863 25 payments
  7. DJO Surgical Empowr Acetabular System $407,801 3 payments
  8. DJO Surgical Empowr Acetabular Cup $407,801 3 payments
  9. DJO SURGICAL Joint Implants $122,290 52 payments
  10. DJO SURGICAL Joint Implants $52,240 46 payments
  11. Other $126,019 210 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

529 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record